3
Announcements
Trials
Browse
Landscape
Status
Completed
245
Terminated
67
Recruiting
21
Unknown
18
Withdrawn
11
Active not recruiting
9
Suspended
1
Not yet recruiting
1
No longer available
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
5
Lymphoid
5
Plasma cell
1
Myeloid
1
Classical hematology
1
Conditions
Multiple Myeloma
6
Sarcoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Endometrial Neoplasms
1
Amyloidosis
1
Interventions
venetoclax
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Plasma cell
×
Clear all
NCT03123029
2026-01-30
Expanded Access to Venetoclax
AbbVie
Available